{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T03:10:10Z","timestamp":1743995410941,"version":"3.40.3"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T00:00:00Z","timestamp":1743984000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T00:00:00Z","timestamp":1743984000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology of Japan","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP18H05282"],"award-info":[{"award-number":["JP18H05282"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP21K16287"],"award-info":[{"award-number":["JP21K16287"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["J200705023"],"award-info":[{"award-number":["J200705023"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["J200705710"],"award-info":[{"award-number":["J200705710"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["J200705049"],"award-info":[{"award-number":["J200705049"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP18 cm016335"],"award-info":[{"award-number":["JP18 cm016335"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP18 cm059042"],"award-info":[{"award-number":["JP18 cm059042"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020408","name":"Kansai Economic Federation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020408","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Mitsubishi Zaidan1"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflamm Regener"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection can lead to severe coronavirus disease 2019 (COVID-19), which is characterized by cytokine storm and organ dysfunction. The spike S1 subunit induces inflammatory cytokine production, but the immune cell subsets that respond to S1 stimulation and contribute to disease severity remain unclear.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>We analyzed serum samples and peripheral blood mononuclear cells (PBMCs) from patients with COVID-19 (moderate: <jats:italic>n<\/jats:italic>\u2009=\u20097; severe: <jats:italic>n<\/jats:italic>\u2009=\u200925) and healthy controls (<jats:italic>n<\/jats:italic>\u2009=\u200938). Using mass cytometry (cytometry by time-of-flight; CyTOF), we analyzed immune cell responses to S1 subunit stimulation in PBMCs from healthy donors and patients with COVID-19. We examined correlations among identified cell populations, serum cytokine levels, and clinical parameters.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Serum S1 subunit levels correlated with disease severity and inflammatory cytokine concentrations. S1 subunit stimulation induced dose-dependent cytokine production from PBMCs, predominantly from myeloid cells. CyTOF analysis identified classical monocytes with high CD147 expression (CD147hi cMono) as the primary source of S1-induced cytokines. The proportion of CD147hi cMono increased significantly in severe COVID-19 and decreased with clinical improvement. The frequency of CD147hi cMono showed a stronger positive correlation with clinical severity markers in younger patients compared to older patients.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>CD147hi cMono are the primary cellular source of S1-induced inflammatory cytokines and may serve as potential biomarkers for monitoring COVID-19 severity and treatment response.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s41232-025-00371-8","type":"journal-article","created":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T02:51:06Z","timestamp":1743994266000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["CD147-high classical monocytes: a cellular biomarker for COVID-19 disease severity and treatment response"],"prefix":"10.1186","volume":"45","author":[{"given":"Teruaki","family":"Murakami","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuta","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saori","family":"Amiya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuko","family":"Yoshimine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinichiro","family":"Nameki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasutaka","family":"Okita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhiro","family":"Kato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haruhiko","family":"Hirata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshito","family":"Takeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Kumanogoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7111-9506","authenticated-orcid":false,"given":"Takayoshi","family":"Morita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,7]]},"reference":[{"key":"371_CR1","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","volume":"579","author":"P Zhou","year":"2020","unstructured":"Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579:270\u20133. https:\/\/doi.org\/10.1038\/s41586-020-2012-7.","journal-title":"Nature"},{"key":"371_CR2","unstructured":"World Health Organization. WHO Coronavirus (COVID-19) Dashboard. http:\/\/covid19.who.int\/. Accessed 5 Dec 2024."},{"key":"371_CR3","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","volume":"395","author":"C Huang","year":"2020","unstructured":"Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan. China Lancet. 2020;395:497\u2013506. https:\/\/doi.org\/10.1016\/S0140-6736(20)30183-5.","journal-title":"China Lancet"},{"key":"371_CR4","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","volume":"395","author":"P Mehta","year":"2020","unstructured":"Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020;395:1033\u20134. https:\/\/doi.org\/10.1016\/S0140-6736(20)30628-0.","journal-title":"Lancet"},{"key":"371_CR5","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","volume":"181","author":"M Hoffmann","year":"2020","unstructured":"Hoffmann M, Kleine-Weber H, Schroeder S, Kr\u00fcger N, Herrler T, Erichsen S, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181:271\u201380. https:\/\/doi.org\/10.1016\/j.cell.2020.02.052.","journal-title":"Cell"},{"key":"371_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2021.e06187","volume":"7","author":"K Shirato","year":"2021","unstructured":"Shirato K, Kizaki T. SARS-CoV-2 spike protein S1 subunit induces pro-inflammatory responses via toll-like receptor 4 signaling in murine and human macrophages. Heliyon. 2021;7: e06187. https:\/\/doi.org\/10.1016\/j.heliyon.2021.e06187.","journal-title":"Heliyon"},{"key":"371_CR7","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1002\/jmv.25987","volume":"92","author":"A Choudhury","year":"2020","unstructured":"Choudhury A, Mukherjee S. In silico studies on the comparative characterization of the interactions of SARS-CoV-2 spike glycoprotein with ACE-2 receptor homologs and human TLRs. J Med Virol. 2020;92:2105\u201313. https:\/\/doi.org\/10.1002\/jmv.25987.","journal-title":"J Med Virol"},{"key":"371_CR8","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1093\/jb\/mvv127","volume":"159","author":"T Muramatsu","year":"2016","unstructured":"Muramatsu T. Basigin (CD147), a multifunctional transmembrane glycoprotein with various binding partners. J Biochem. 2016;159:481\u201390. https:\/\/doi.org\/10.1093\/jb\/mvv127.","journal-title":"J Biochem"},{"key":"371_CR9","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1111\/j.1365-2249.2010.04115.x","volume":"160","author":"V Yurchenko","year":"2010","unstructured":"Yurchenko V, Constant S, Eisenmesser E, Bukrinsky M. Cyclophilin-CD147 interactions: a new target for anti-inflammatory therapeutics. Clin Exp Immunol. 2010;160:305\u201317. https:\/\/doi.org\/10.1111\/j.1365-2249.2010.04115.x.","journal-title":"Clin Exp Immunol"},{"key":"371_CR10","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/s41392-020-00426-x","volume":"5","author":"K Wang","year":"2020","unstructured":"Wang K, Chen W, Zhang Z, Deng Y, Lian JQ, Du P, et al. CD147-spike protein is a novel route for SARS-CoV-2 infection to host cells. Signal Transduct Target Ther. 2020;5:283. https:\/\/doi.org\/10.1038\/s41392-020-00426-x.","journal-title":"Signal Transduct Target Ther"},{"key":"371_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.scitotenv.2021.152072","volume":"808","author":"T Behl","year":"2022","unstructured":"Behl T, Kaur I, Aleya L, Sehgal A, Singh S, Sharma N, et al. CD147-spike protein interaction in COVID-19: Get the ball rolling with a novel receptor and therapeutic target. Sci Total Environ. 2022;808: 152072. https:\/\/doi.org\/10.1016\/j.scitotenv.2021.152072.","journal-title":"Sci Total Environ"},{"key":"371_CR12","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s13578-022-00822-6","volume":"12","author":"S Badeti","year":"2022","unstructured":"Badeti S, Jiang Q, Nahizadeh A, Tseng HC, Bushkin Y, Marras SAE, et al. Development of a novel human CD147 knock-in NSG mouse model to test SARS-CoV-2 viral infection. Cell Biosci. 2022;12:88. https:\/\/doi.org\/10.1186\/s13578-022-00822-6.","journal-title":"Cell Biosci"},{"key":"371_CR13","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/s41392-021-00603-6","volume":"6","author":"H Bian","year":"2021","unstructured":"Bian H, Zheng ZH, Wei D, Zhang Z, Kang WZ, Hao CQ, et al. Safety and efficacy of meplazumab in healthy volunteers and COVID-19 patients: a randomized phase 1 and an exploratory phase 2 trial. Signal Transduct Target Ther. 2021;6:194. https:\/\/doi.org\/10.1038\/s41392-021-00603-6.","journal-title":"Signal Transduct Target Ther"},{"key":"371_CR14","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/s41392-023-01323-9","volume":"8","author":"H Bian","year":"2023","unstructured":"Bian H, Chen L, Zheng ZH, Sun XX, Geng JJ, Chen R, et al. Meplazumab in hospitalized adults with severe COVID-19 (DEFECT): a multicenter, seamless phase 2\/3, randomized, third-party double-blind clinical trial. Signal Transduct Target Ther. 2023;8:46. https:\/\/doi.org\/10.1038\/s41392-023-01323-9.","journal-title":"Signal Transduct Target Ther"},{"key":"371_CR15","unstructured":"World Health Organization. WHO COVID-19 Case definition. http:\/\/www.who.int\/publications-detail-redirect\/WHO-2019-nCoV-Surveillance_Case_Definition-2022.1. Accessed 12 Mar 2024."},{"key":"371_CR16","doi-asserted-by":"publisher","unstructured":"Nowicka M, Robinson MD, Habib N, Haghverdi L, Battich N, Ganzfried BF, et al. CyTOF workflow: differential discovery in high-throughput high-dimensional cytometry datasets. F1000Res. 2017;6:748. https:\/\/doi.org\/10.12688\/f1000research.11622.4.","DOI":"10.12688\/f1000research.11622.4"},{"key":"371_CR17","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1038\/s41467-022-29356-8","volume":"13","author":"CB Pedersen","year":"2022","unstructured":"Pedersen CB, Joshi I, Sun JC, Schmitz A, Ay F, Chen DS, et al. cyCombine allows for robust integration of single-cell cytometry datasets within and across technologies. Nat Commun. 2022;13:1698. https:\/\/doi.org\/10.1038\/s41467-022-29356-8.","journal-title":"Nat Commun"},{"key":"371_CR18","doi-asserted-by":"crossref","first-page":"9959","DOI":"10.18632\/aging.103344","volume":"12","author":"AL Mueller","year":"2020","unstructured":"Mueller AL, McNamara MS, Sinclair DA. Why does COVID-19 disproportionately affect older people? Aging (Albany NY). 2020;12:9959\u201381.","journal-title":"Aging (Albany NY)"},{"key":"371_CR19","doi-asserted-by":"publisher","first-page":"6360","DOI":"10.1073\/pnas.111583198","volume":"98","author":"T Pushkarsky","year":"2001","unstructured":"Pushkarsky T, Zybarth G, Dubrovsky L, Yurchenko V, Tang H, Guo H, et al. CD147 facilitates HIV-1 infection by interacting with virus-associated cyclophilin A. Proc Natl Acad Sci USA. 2001;98:6360\u20135. https:\/\/doi.org\/10.1073\/pnas.111583198.","journal-title":"Proc Natl Acad Sci USA"},{"key":"371_CR20","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1086\/427811","volume":"191","author":"Z Chen","year":"2005","unstructured":"Chen Z, Mi L, Xu J, Yu J, Wang X, Jiang J, et al. Function of HAb18G\/CD147 in invasion of host cells by severe acute respiratory syndrome coronavirus. J Infect Dis. 2005;191:755\u201360. https:\/\/doi.org\/10.1086\/427811.","journal-title":"J Infect Dis"},{"key":"371_CR21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41392-021-00710-4","volume":"7","author":"J Wu","year":"2022","unstructured":"Wu J, et al. CD147 contributes to SARS-CoV-2-induced pulmonary fibrosis. Sig Transduct Target Ther. 2022;7:1\u201313.","journal-title":"Sig Transduct Target Ther"},{"key":"371_CR22","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1165\/rcmb.2002-0059OC","volume":"28","author":"T Betsuyaku","year":"2003","unstructured":"Betsuyaku T, Kadomatsu K, Griffin GL, Muramatsu T, Senior RM. Increased Basigin in Bleomycin-Induced Lung Injury. Am J Respir Cell Mol Biol. 2003;28:600\u20136.","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"1","key":"371_CR23","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s12964-023-01417-2","volume":"22","author":"A Villacampa","year":"2024","unstructured":"Villacampa A, Alfaro E, Morales C, et al. SARS-CoV-2 S protein activates NLRP3 inflammasome and deregulates coagulation factors in endothelial and immune cells. Cell Commun Signal. 2024;22(1):38. https:\/\/doi.org\/10.1186\/s12964-023-01417-2.","journal-title":"Cell Commun Signal"},{"issue":"10229","key":"371_CR24","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","volume":"395","author":"F Zhou","year":"2020","unstructured":"Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054\u201362. https:\/\/doi.org\/10.1016\/S0140-6736(20)30566-3.","journal-title":"Lancet"},{"issue":"7","key":"371_CR25","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1515\/cclm-2020-0369","volume":"58","author":"BM Henry","year":"2020","unstructured":"Henry BM, de Oliveira MHS, Benoit S, Plebani M, Lippi G. Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis. Clin Chem Lab Med. 2020;58(7):1021\u20138. https:\/\/doi.org\/10.1515\/cclm-2020-0369.","journal-title":"Clin Chem Lab Med"},{"key":"371_CR26","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/s41590-017-0006-x","volume":"19","author":"J Nikolich-\u017dugich","year":"2018","unstructured":"Nikolich-\u017dugich J. The twilight of immunity: emerging concepts in aging of the immune system. Nat Immunol. 2018;19:10\u20139. https:\/\/doi.org\/10.1038\/s41590-017-0006-x.","journal-title":"Nat Immunol"},{"key":"371_CR27","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.698169","volume":"12","author":"AD Proal","year":"2021","unstructured":"Proal AD, VanElzakker MB. Long COVID or post-acute sequelae of COVID-19 (PASC): an overview of biological factors that may contribute to persistent symptoms. Front Microbiol. 2021;12: 698169. https:\/\/doi.org\/10.3389\/fmicb.2021.698169.","journal-title":"Front Microbiol"},{"key":"371_CR28","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n1648","volume":"374","author":"H Crook","year":"2021","unstructured":"Crook H, Raza S, Nowell J, Young M, Edison P. Long covid\u2014mechanisms, risk factors, and management. BMJ. 2021;374: n1648. https:\/\/doi.org\/10.1136\/bmj.n1648.","journal-title":"BMJ"},{"key":"371_CR29","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1186\/s13054-022-04153-3","volume":"26","author":"KD Wick","year":"2022","unstructured":"Wick KD, et al. Plasma SARS-CoV-2 nucleocapsid antigen levels are associated with progression to severe disease in hospitalized COVID-19. Crit Care. 2022;26:278.","journal-title":"Crit Care"}],"container-title":["Inflammation and Regeneration"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41232-025-00371-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41232-025-00371-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41232-025-00371-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T02:51:22Z","timestamp":1743994282000},"score":1,"resource":{"primary":{"URL":"https:\/\/inflammregen.biomedcentral.com\/articles\/10.1186\/s41232-025-00371-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,7]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["371"],"URL":"https:\/\/doi.org\/10.1186\/s41232-025-00371-8","relation":{},"ISSN":["1880-8190"],"issn-type":[{"value":"1880-8190","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,7]]},"assertion":[{"value":"22 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of Osaka University Graduate School of Medicine (No. 18050). All participants provided written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Atsushi Kumanogoh is an Editor in Chief of this journal (Inflammation and Regeneration). The other authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"8"}}